These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9177526

  • 21. Ursodeoxycholic acid for chronic liver diseases.
    Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M.
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [Abstract] [Full Text] [Related]

  • 22. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
    Ricci P, Hofmann AF, Hagey LR, Jorgensen RA, Rolland Dickson E, Lindor KD.
    Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ.
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [Abstract] [Full Text] [Related]

  • 25. Unsaturated monohydroxy bile acids in cholestatic liver disease.
    Murphy GM, Jansen FH, Billing BH.
    Biochem J; 1972 Sep; 129(2):491-4. PubMed ID: 4643332
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J, Białek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O.
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The rationale for using ursodeoxycholic acid in chronic liver disease.
    Heller FR, Martinet JP, Henrion J, Schapira M, Gallez JF.
    Acta Gastroenterol Belg; 1990 Apr; 53(4):402-8. PubMed ID: 2096588
    [Abstract] [Full Text] [Related]

  • 31. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR, Allen RM, Klatskin G.
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [Abstract] [Full Text] [Related]

  • 32. [Ursodeoxycholic acid lowers liver enzymes].
    Leuschner U.
    Leber Magen Darm; 1989 Sep; 19(5):276. PubMed ID: 2811579
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.
    Ikeda T, Tozuka S, Noguchi O, Kobayashi F, Sakamoto S, Marumo F, Sato C.
    J Hepatol; 1996 Jan; 24(1):88-94. PubMed ID: 8834030
    [Abstract] [Full Text] [Related]

  • 35. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R.
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.